Search
for
Sort by
Research 271–300 of 537
- Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women
- 11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
- The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
- An Overview of Growth Factors as the Potential Link between Psoriasis and Metabolic Syndrome
- Quercetin and polycystic ovary syndrome
- Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Hair cortisol in polycystic ovary syndrome
- Debatable Topics in PCOS Patients
- The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
- Lean Women with Polycystic Ovary Syndrome
- Serum phoenixin-14 and phoenixin-20 concentrations in polycystic ovary syndrome: Associations with anti-Müllerian hormone and diagnostic utility
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Multivariate Profiles of Female Sexual Function: A Cluster Analysis of FSFI Domains in Women with and Without PCOS
- Evaluation of dihydrotestosterone levels and total testosterone to dihydrotestosterone ratio with clinical symptoms and metabolic parameters in patients with polycystic ovary syndrome
- Use of Myoinositol in PCOS
- Dietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS
- Understanding Polycystic Ovary Syndrome
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Phenotypic Characterization of Patients with Polycystic Ovary Syndrome in a Population from the Ecuadorian Andes: A Cross-Sectional Study
- ВПЛИВ ІНОЗИТОЛУ НА ЖІНОК ІЗ СИНДРОМОМ ПОЛІКІСТОЗНИХ ЯЄЧНИКІВ ТА ОЖИРІННЯМ: МЕТАБОЛІЧНІ ТА РЕПРОДУКТИВНІ АСПЕКТИ
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome
- Dermatoses in overweight and obese children and their relationship with insulin and skin color
- Ameliorative Impact of High Inositol Diet on the Insulin Resistance and Metabolite Hormones among Women with Polycystic Ovary Syndrome
- Rare and Underappreciated Causes of Polycystic Ovarian Syndrome
- Efficacy of Clinical and Pathogenetic Treatment of Patients with Alopecia Areata Associated with Metabolic Syndrome